Duration of response and tumor shrinkage with first-line ribociclib plus letrozole in postmenopausal women with HR1, HER2-ABC
ANNALS OF ONCOLOGY（2017）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined